Your browser doesn't support javascript.
loading
Disruption of IGF­1R signaling by a novel quinazoline derivative, HMJ­30, inhibits invasiveness and reverses epithelial-mesenchymal transition in osteosarcoma U­2 OS cells.
Chiu, Yu-Jen; Hour, Mann-Jen; Jin, Yi-An; Lu, Chi-Cheng; Tsai, Fuu-Jen; Chen, Tai-Lin; Ma, Hsu; Juan, Yu-Ning; Yang, Jai-Sing.
Afiliação
  • Chiu YJ; Division of Plastic and Reconstructive Surgery, Department of Surgery, Taipei Veteran General Hospital, Taipei 112, Taiwan, R.O.C.
  • Hour MJ; School of Pharmacy, China Medical University, Taichung 404, Taiwan, R.O.C.
  • Jin YA; Department of Dermatology, Taipei Medical University Hospital, Taipei 110, Taiwan, R.O.C.
  • Lu CC; Department of Pharmacy, Buddhist Tzu Chi General Hospital, Hualien 970, Taiwan, R.O.C.
  • Tsai FJ; Genetics Center, Department of Medical Research, China Medical University Hospital, Taichung 404, Taiwan, R.O.C.
  • Chen TL; Institute of Biochemistry and Molecular Biology, National Yang Ming University, Taipei 112, Taiwan, R.O.C.
  • Ma H; Division of Plastic and Reconstructive Surgery, Department of Surgery, Taipei Veteran General Hospital, Taipei 112, Taiwan, R.O.C.
  • Juan YN; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan, R.O.C.
  • Yang JS; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan, R.O.C.
Int J Oncol ; 52(5): 1465-1478, 2018 May.
Article em En | MEDLINE | ID: mdl-29568964

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article